Summary
- Current Price
- As of today, RGC price is $26.23, down -0.23% on
- Current Price All-Time High
- RGC price is currently -93.09% below its historical high of $379.50 set on
- Market Cap
- RGC current market cap is $13B, up +20408.21% over the past 365 days
- PE Ratio
- RGC PE ratio is unknown
- Revenue
- RGC current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RGC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Regencell Bioscience Holdings Limited |
| Ticker | NASDAQ: RGC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Hong Kong |
| IPO | |
| Indexes | Not included |
| Website | regencellbioscience.com |
| Employees | 12 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $26.23 | |
| Price, 1D Change | -0.23% | |
| Market Cap | $13B | |
| - | ||
| PE Ratio | - | |
| Beta | -4.45 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.01 | |
| EPS, 1Y Change | +97.82% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 38:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.01 | |
| EPS Estimate | - | |
| EPS Est. Change | - | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $26.23 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +20,408.21% | |
| Price, 3Y | +3,474.06% | |
| Market Cap, 1Y | +20,408.21% | |
| Market Cap, 3Y | +3,474.06% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +97.82% | |
| EPS, 3Y | +98.77% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $26.23 | |
| SMA 200 | $19.18 | |
| SMA 200 vs Price | -26.87% | |
| SMA 50 | $28.29 | |
| SMA 50 vs Price | +7.84% | |
| Beta | -4.45 | |
| ATR | $3.60 | |
| 14-Day RSI | 45.93 | |
| 10-Day Volatility | 94.79% | |
| 1-Year Volatility | 6,499.51% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.01 | |
| Gross Profit | -$392.70K | |
| - | ||
| Operating Profit | -$3.77M | |
| - | ||
| Net Income | -$3.58M | |
| - | ||
| EBITDA | -$3.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.11 | |
| 7.39 | ||
| 7.39 | ||
| - | ||
| - | ||
| 8,684.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 1,931.45 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $4.86M | |
| $4.90M | ||
| $5.76M | ||
| $4.90M | ||
| $895.30K | ||
| $663.70K | ||
| Total Debt | $544.40K | |
| $312.80K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $3.58M | ||
| $3.38M | ||
| $392.70K | ||
| $0.00 | ||
| $392.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$3.11M | ||
| $2.69M | ||
| $0.00 | ||
| Capex | $152.70K | |
| -$3.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with RGC
FAQ
What is the ticker symbol for Regencell Bioscience Holdings Limited?
The ticker symbol for Regencell Bioscience Holdings Limited is NASDAQ:RGC
Does Regencell Bioscience Holdings Limited pay dividends?
No, Regencell Bioscience Holdings Limited does not pay dividends
What sector is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Healthcare sector
What industry is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Specialty & Generic Drug Manufacturers industry
What country is Regencell Bioscience Holdings Limited based in?
Regencell Bioscience Holdings Limited is headquartered in Hong Kong
When did Regencell Bioscience Holdings Limited go public?
Regencell Bioscience Holdings Limited initial public offering (IPO) was on July 16, 2021
Is Regencell Bioscience Holdings Limited in the S&P 500?
No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index
Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index
Is Regencell Bioscience Holdings Limited in the Dow Jones?
No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index
When was Regencell Bioscience Holdings Limited last earnings report?
Regencell Bioscience Holdings Limited's most recent earnings report was on November 18, 2025
When does Regencell Bioscience Holdings Limited report earnings?
The next expected earnings date for Regencell Bioscience Holdings Limited is June 2, 2026
Data Sources & References
- RGC Official Website www.regencellbioscience.com
- RGC Profile on Yahoo Finance finance.yahoo.com/quote/RGC
- RGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgc